Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/Ib Trial of Single Agent PBF-999 in Solid Tumour Advanced Cancer

NCT03786484 is registered in ClinicalTrials.gov with Palobiofarma SL as lead sponsor.

NCT NCT03786484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03786484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/Ib Trial of Single Agent PBF-999 in Solid Tumour Advanced Cancer
Lead sponsor
Palobiofarma SL
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2017
Completion date
June 30, 2022
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer